Drug Type Small molecule drug |
Synonyms Pidotimod (INN), Pidotimod Dispersible + [13] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2001), |
Regulation- |
Molecular FormulaC9H12N2O4S |
InChIKeyUUTKICFRNVKFRG-WDSKDSINSA-N |
CAS Registry121808-62-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Tract Infections | China | 01 Jan 2001 | |
Urinary Tract Infections | China | 01 Jan 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Phase 2 | China | 09 Nov 2014 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | China | 09 Nov 2014 | |
Gynecological infection | Phase 2 | China | 21 Nov 2013 | |
Lower Respiratory Tract Infections | Phase 2 | China | 21 Nov 2013 | |
Otitis Media | Phase 2 | China | 21 Nov 2013 | |
Urinary Tract Infections | Phase 2 | China | 21 Nov 2013 | |
Bronchitis | Phase 2 | China | 29 Oct 2013 | |
Bronchitis | Phase 2 | China | 29 Oct 2013 | |
Brain Infarction | Phase 2 | China | - | 25 Oct 2013 |
Bronchitis | Phase 1 | China | - | 29 Oct 2013 |